2000
DOI: 10.1016/s0165-5728(00)00364-7
|View full text |Cite
|
Sign up to set email alerts
|

Immunosuppression prevents neuronal atrophy in lupus-prone mice:

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
1

Year Published

2004
2004
2020
2020

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 49 publications
(9 citation statements)
references
References 53 publications
0
8
0
1
Order By: Relevance
“…Some evidence does suggest a role for serum autoantibody levels in NP-SLE, as mice with more severe peripheral and behavioral manifestations of SLE also have more pronounced changes in hippocampal and cortical morphology and increased indices of cell death [163166]. This can be prevented with doses of cyclophosphamide that reduce serum autoantibody titers [165], although CSF levels of autoantibodies were not assessed. However, IgG levels in serum, but not CSF, are positively correlated with spleen weight, suggesting that central autoimmune processes are relatively independent from systemic manifestations [167].…”
Section: Cns Mechanisms and Pathologymentioning
confidence: 99%
“…Some evidence does suggest a role for serum autoantibody levels in NP-SLE, as mice with more severe peripheral and behavioral manifestations of SLE also have more pronounced changes in hippocampal and cortical morphology and increased indices of cell death [163166]. This can be prevented with doses of cyclophosphamide that reduce serum autoantibody titers [165], although CSF levels of autoantibodies were not assessed. However, IgG levels in serum, but not CSF, are positively correlated with spleen weight, suggesting that central autoimmune processes are relatively independent from systemic manifestations [167].…”
Section: Cns Mechanisms and Pathologymentioning
confidence: 99%
“…It should be noted that neurological defects present in aged lpr (Fas KO , only 10% normal expression) and gld (FasL KO ) mice, have both an immunological and neurological etiology. As they approach adulthood, Fas KO and FasL KO mice develop extensive peripheral autoimmune disease, followed by the acquisition of neuropathy characterized by extensive inflammation (Ma et al, 2006), accelerating neuronal apoptosis and depletion, brain atrophy, and behavioral degeneration (Sakic et al, 1992, 2000a,b, 2002; Watanabe-Fukunaga et al, 1992; Takahashi et al, 1994; Ballok et al 2003a, 2004a; Anderson et al, 2006; Ma et al, 2006; Sled et al, 2009). The neuronal effect of aberrant Fas/FasL expression has been predominantly studied on mice of the MRL-lpr background, which spontaneously develop age-dependent autoimmune disease similar to human autoimmune systemic lupus erythematosus (SLE) combined with lymphadenopathy (Sakic et al, 2002).…”
Section: The Neurological Role Of Fasl and Its Receptormentioning
confidence: 99%
“…The alkylating agent cyclophosphamide (CY) is effective in arresting systemic autoimmunity via its metabolite phosphoramide mustard, which is formed in cells with low levels of aldehyde dehydrogenase and leads to apoptosis by forming DNA crosslinks. Given that chronic exposure to CY prevents neurodegeneration and normalizes behavior in autoimmune mice [55,[96][97][98], an identical, well-established protocol that does not involve injection-induced stress was chosen as a treatment modality in the current study. To provide consistency and comparability across studies, previously used behavioral, cellular and molecular variables [53,65] were analyzed.…”
Section: Introductionmentioning
confidence: 99%